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COMPUTATIONAL IDENTIFICATION OF NONCODING DRIVER MUTATIONS
BASED ON IMPACT ON RNA PROCESSING
Kevin Wen Zhu, B.A.
Advisory Professor: Jeffrey T. Chang, Ph.D.
Despite the prevalence of mutations in the noncoding regions of the DNA, their
effects on cancer development remain largely uninvestigated. This is especially
evident when compared to coding mutations, which have been relatively well-studied
and, in certain cases, been identified as driver mutations for cancer. Recent studies,
however, have identified noncoding mutations that frequently appear in certain types
of cancer, which may be evidence that those mutations are important to cancer
development. Nonetheless, the role of noncoding mutations in cancer remains
unclear. A potential vector for understanding this mechanism is through observing
the relation between noncoding mutations and functional RNA motifs. The goals for
this study, therefore, were to identify RNA motifs that were significantly associated
with the presence of somatic, noncoding mutations and to predict the functional
impact of noncoding variants. The analysis was conducted on mutations detected in
whole genome sequencing profiles of breast cancer samples obtained from the
TCGA database. I derived the significance of the number of noncoding mutations
affecting a particular motif as well as the enrichment of noncoding mutations on each
motif. I also created linear models to identify the motifs with mutations that had the
greatest impact on cancer-related pathways. I found that a number of motifs are
affected by significantly less mutations than we would expect at random.
Additionally, I found that functional RNA motifs related to splicing are often
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significant in the linear models, suggesting that they play a role the relation between
noncoding mutations and cancer. These findings will help improve understanding of
the effects of noncoding mutations on RNA processing in the context of breast
cancer.
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INTRODUCTION
1. Driver Mutations
Random mutations that occur during DNA replication are the leading cause of
known cancer incidences (Tomasetti and Vogelstein, 2015). However, only a
portion of these mutations promote tumorigenesis. Driver mutations provide a
selective advantage that allows a cell or cell population to grow and avoid cell death
or senescence. Other mutations, known as passenger mutations, do not provide
such an advantage, but may accompany the driver mutations during clonal
expansion because of their presence in the same genome. Passenger mutations
may have arisen before or after the clonal cells have developed into cancer (Wood,
et al., 2007).

2. Coding and Noncoding Mutations
Until recently, cancer driver mutations have been found only among
mutations in the coding regions of the genome, or those regions that are eventually
transcribed into proteins. This is because it is relatively easy to predict the
consequences or impact of mutations on the encoded protein, which can be either
gain or loss of protein function due to changes in expression, folding, trafficking, or
posttranslational modification. For this reason, the majority of the sequence data in
cancer sequencing database only contain exon sequences, leaving possible driver
variants in the noncoding sequences, which are genomic sequences that do not
encode protein sequences, undetected.
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Figure 1. How a driver mutation can cause normal tissue to develop into
cancer. Pre-existing passenger mutations do not contribute to the
development of the cancer. Once a driver mutation affects a cell, the cell
gains a selective advantage that allows it to grow and cause the tissue to
become tumorous.
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Typically, driver coding mutations have been identified based on their
frequency in cancer samples or by their functional impact. In the former, genes that
are mutated in a significantly greater number of cancer samples when compared to
a background rate are regarded as candidate driver genes. Somatic coding
mutations on these genes are then identified as candidate drivers based on the
consistency and predictability of their effects on the function of the protein encoded
by the gene. Functional impact is then used to differentiate between driver and
passenger mutations by identifying the mutations that generally have a stronger
impact on protein function as it relates to cell growth and survival (Pon and Marra,
2015).
However, it is estimated that coding regions account for only 2% of the
human genome (Elgar and Vavouri, 2008; Lee et al., 2010), which means that
noncoding regions that make up the other 98% have largely been ignored when
identifying possible cancer driver mutations. As shown in Figure 2, there are a
proportional number of noncoding variants in the breast cancer samples when whole
genome sequences are considered. This means that a large number of mutations
have yet to be studied. There are several reasons for the lack of research into
noncoding mutations in cancer, among which the biggest issue is the sample size.
As noted, the sheer number of variants in the noncoding regions far exceeds that of
those found in the coding regions, which can lead to difficulty in identifying recurrent
mutations with statistical significance. Current solutions have focused on
transcriptional regulatory regions, but this ignores the fact that gene products are
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Figure 2. Average percentage of coding and noncoding variants
across 28 TCGA breast cancer samples analyzed in this study.
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processed in other ways that affect function. Therefore, the effects of noncoding
mutations are more difficult to discern compared to those of coding mutations (Elgar
and Vavouri, 2008).

3. History
Because of our limited understanding of noncoding variants and their effects,
it is difficult to discern if any such variants could be considered a driver mutation and
the large number of noncoding variants makes it difficult to even identify potential
candidates. Nonetheless, recent efforts have been made to facilitate finding
important noncoding mutations by restricting the scope of the population, typically by
searching for mutations recurrent across multiple samples. For example, one
important study identified potential driver mutations in the promoter region of TERT
by analyzing a number of melanoma samples for recurrent mutations and finding two
that were collectively present in 70% of melanoma cases studied (Huang et al.,
2013). Since then, other studies have further restricted the number of noncoding
mutations by using techniques that rely on identifying recurrent mutations based on
genomic regions. For example, hotspot analysis identifies short regions of the
genome (e.g., 50 bps) in which more mutations appear relative to nearby regions.
Another method is the regional mutation recurrence, which looks for sets of regions
with similar properties, such as nucleotide makeup or other sequence features, and
identifies the sets that carry more mutation compared to other sets (Weinhold, et al.,
2014). In one study, for example, researchers identified a notable enrichment of
mutations in the regulatory elements of ESR1 in 7% of ESR1-positive breast
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cancers, compared to just 1% of somatic copy number alterations in the same
cancer type (Bailey et al., 2016). Another common approach is to search areas
where important mutations are known to occur, such as the promoter regions as
identified in the TERT study. FOXA1, along with a number of other genes, has been
identified in breast cancer as a potential driver gene based on recurrent mutations
present in its promoter region (Rheinbay et al., 2017).
Other methods that have been used to facilitate looking through noncoding
mutation is by attempting to discern which mutations have more significant effects
based on gene expression (Fredriksson, et al., 2014). This method involves
evaluating genes for associations between RNA levels and noncoding somatic
mutations. While the mutations were originally identified via location-based methods,
as mentioned previously, the researchers in the FOXA1 study observed that the
mutations in the FOXA1 promoter region impacted gene expression and caused an
increase in the amount of FOXA1 protein, which would then result in increased
sensitivity to estrogen in affected cells (Rheinbay et al., 2017). This allowed them to
not only further confirm their observation, but also develop another possible method
for identifying candidate noncoding driver mutations.

4. Functional RNA Motifs
While there has been progress in identifying the mechanisms connecting
noncoding mutations and cancer, current analyses has been limited due to largely
focusing on transcriptional regulatory regions. Since gene products are processed
in other ways that can affect function, it may be possible to improve identification of
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noncoding driver mutations by looking at regions that affect other aspects of nontranscriptional regulation. One potential vector for understanding the general
relation between noncoding variants and cancer is through exploring their
connection with RNA processing. As RNA matures, it goes through a sequence of
steps that impact the regulation of gene expression, alternative splicing,
transcriptional termination, and others. The sequences of elements predictive of
sites of processing have been represented as motifs and can be predicted from the
sequence (Chang et al., 2013). So far, however, there has been little research into
whether RNA motifs can be used to identify regions of the genome enriched for
noncoding mutations. Therefore, in order to examine the contributions of noncoding
mutations to tumorigenesis, the goal of this thesis was to develop computational
approaches to identifying driver mutations in the noncoding regions of the genome
that impact cancer development based on their effect on functional RNA motifs.

5. Breast Cancer
Breast cancer stands out as one of the most prevalent cancers among
women in the United States and the second-leading cause of cancer-related death
among women after lung and bronchus cancer (American Cancer Society, 2016).
Because of this, there is a relatively large amount of available sequencing data,
including whole genome sequences, for breast cancer (Weinstein et al., 2013). The
large dataset is very important for statistical evaluation in computational methods.
Moreover, while mutations in the noncoding regions of particular genes have been
identified in breast cancer, melanoma, bladder cancer, glioblastomas, and other
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cancers, there are still a large number of noncoding mutations that have not been
analyzed due to the focus on transcriptional regulatory regions in previous studies
(Huang et al., 2013; Horn et al., 2013; Fredriksson et al., 2014; Weinhold et al.,
2014). Thus, noncoding mutations remain poorly explored in cancer research.
Although there is still much that needs to be done before the relation between
noncoding mutations and cancer is fully understood, focusing on breast cancer may
yield important insights on possible driver mutations in the noncoding regions that
impact cancer development, which would benefit patients and society.
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HYPOTHESIS AND SPECIFIC AIMS
I hypothesize that functional noncoding mutations are enriched in genomic
sequences that impact RNA processing.
To test the hypothesis, I identified two specific aims (Figure 3).
Aim 1: To develop computational methods for identifying RNA motifs that are
significantly associated with the presence of somatic, noncoding mutations.
Approach: I first predicted RNA motifs, then performed a statistical analyses in order
to identify those that were significantly associated with noncoding mutations. For the
statistics, I compared the data against similar, but random locations in the genome
to identify if there was a significant difference in the number of mutations affecting a
particular motif.
Results: I discovered that some of the motifs have a significant association with
noncoding mutations. Each motif that showed significance displayed negative
enrichment of mutations affecting the motifs relative to the randomly selected
locations, implying that the number of mutations affecting those motifs was less than
would be expected at random.
Aim 2: To predict functional impact of noncoding variants.
Approach: I looked for potential associations between RNA motifs affected by
noncoding mutations and known cancer pathways. I estimated the activation of the
pathways using gene expression information. I then applied regression analysis to
identify RNA motifs predictive of functional activity.
Results: This analysis revealed that certain motifs consistently have a significant
association with the cell cycle pathway. Expanding the analysis to other pathways
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revealed that splicing-related motifs were often significant in the pathways that were
most impacted. This suggests that splicing-related motifs have a significant impact
in the relation between noncoding motifs and breast cancer.
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Figure 3. Overall pipeline to accomplish specific aims
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METHODS
1. Data Processing and Variant Identification
I obtained whole genome sequenced (WGS) breast cancer (BRCA) samples
from The Cancer Genome Atlas (TCGA) (Weinstein et al., 2013). The samples I
used for the study were primarily those with the largest file sizes, which suggested
that they would have greater read depth. Each sample consists of a patient’s tumor
sample as well as a paired normal sample, which allows us to filter out germline and
SNPs during variant calling. Of the 1084 patients with breast cancer samples
available from the TCGA, 118 had WGS analysis done on them. BAM files were
downloaded from the Cancer Genomics Hub (CGHub) or the Genomic Data
Commons (GDC). Samples originated either from the Washington University
Genome Sequencing Center (WUGSC) or Raju Kucherlapati’s lab at the Harvard
Medical School (HMS-RK). Because the preprocessing differs between the sources,
I first preprocessed the files again to ensure consistency. To do this, I used an inhouse program known as BETSY, which was in our lab (Chen and Chang, 2017). I
realigned the sequences using BWA-MEM (Li, 2013), marked duplicates, added
read groups, realigned insertions and deletions, and sorted by coordinates (Desprito,
et al., 2011). The list of tumor samples and their corresponding normal samples are
presented in Table 1.
After I processed both the tumor and normal samples for a patient, I used the
variant caller MuTect to identify the possible mutations (Cibulskis et al., 2013).
MuTect takes as input the paired patient samples as well as a reference genome,
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Figure 4. Pipeline for data processing
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TCGA ID (Tumor File)

TCGA ID (Normal File)

Center

TCGA-B6-A0X4-01A-11D-A106-02

TCGA-B6-A0X4-10A-01D-A106-02

HMS-RK

TCGA-B6-A0RE-01A-11D-A060-02

TCGA-B6-A0RE-10A-01D-A128-09

HMS-RK

TCGA-E2-A15K-06A-11D-A12Q-09

TCGA-E2-A15K-10A-01D-A12Q-09

WUGSC

TCGA-E2-A109-01A-11D-A10M-09

TCGA-E2-A109-10A-01D-A10M-09

WUGSC

TCGA-A7-A0CE-01A-11D-A12L-09

TCGA-A7-A0CE-11A-21D-A12L-09

WUGSC

TCGA-A2-A0D2-01A-21D-A128-09

TCGA-A2-A0D2-10A-01D-A128-09

WUGSC

TCGA-EW-A3U0-01A-11D-A228-09

TCGA-EW-A3U0-10A-01D-A22A-09

WUGSC

TCGA-E2-A1LG-01A-21D-A14K-09

TCGA-E2-A1LG-11A-42D-A14K-09

WUGSC

TCGA-A7-A13D-01A-13D-A12Q-09

TCGA-A7-A13D-10A-02D-A12Q-09

WUGSC

TCGA-A7-A26G-01A-21D-A167-09

TCGA-A7-A26G-10A-01D-A314-09

WUGSC

TCGA-D8-A27H-01A-11D-A314-09

TCGA-D8-A27H-10A-01D-A17G-09

WUGSC

TCGA-A2-A259-01A-11D-A314-09

TCGA-A2-A259-10A-01D-A17G-09

WUGSC

TCGA-AN-A0AT-01A-11D-A045-09

TCGA-AN-A0AT-10A-01D-A047-09

WUGSC

TCGA-EW-A1P8-01A-11D-A142-09

TCGA-EW-A1P8-10A-01D-A314-09

WUGSC

TCGA-BH-A18R-01A-11D-A19H-09

TCGA-BH-A18R-11A-42D-A19H-09

WUGSC

TCGA-BH-A0DT-01A-21D-A12B-09

TCGA-BH-A0DT-11A-12D-A12B-09

WUGSC

TCGA-AN-A0G0-01A-11D-A045-09

TCGA-AN-A0G0-10A-01D-A047-09

WUGSC

TCGA-E2-A152-01A-11D-A19H-09

TCGA-E2-A152-10A-01D-A19H-09

WUGSC

TCGA-A2-A3KC-01A-11D-A20S-09

TCGA-A2-A3KC-10A-01D-A20S-09

WUGSC

TCGA-A8-A094-01A-11D-A19H-09

TCGA-A8-A094-10A-01D-A19H-09

WUGSC

TCGA-AO-A03L-01A-41D-A19H-09

TCGA-AO-A03L-10A-01D-A19H-09

WUGSC

TCGA-A8-A075-01A-11D-A19H-09

TCGA-A8-A075-10B-01D-A19H-09

WUGSC

TCGA-A2-A04Q-01A-21D-A128-09

TCGA-A2-A04Q-10A-01D-A128-09

WUGSC

TCGA-B6-A0I6-01A-11D-A128-09

TCGA-B6-A0I6-10A-01D-A128-09

WUGSC

TCGA-AO-A0JM-01A-21D-A19H-09

TCGA-AO-A0JM-10A-01D-A19H-09

WUGSC

TCGA-AO-A0J2-01A-11D-A19H-09

TCGA-AO-A0J2-10A-01D-A19H-09

WUGSC

TCGA-B6-A0IJ-01A-11D-A128-09

TCGA-B6-A0IJ-10A-01D-A128-09

WUGSC

TCGA-B6-A0RT-01A-21D-A128-09

TCGA-B6-A0RT-10A-01D-A128-09

WUGSC

Table 1. List of tumor sample IDs, matched normal sample ID, and the
originating lab
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thus allowing it to filter out germline mutations. Additionally, MuTect will accept as
input files containing data from the COSMIC database and the dbsnp database,
which are used as additional references for MuTect’s calculations. As output,
MuTect presents its results as a tab-delimited text file, which includes columns for
various statistics, such as read depths for both the tumor and normal sample and the
allele frequencies for reference and variant alleles in both samples. Furthermore,
the caller can suggest whether a particular variant may be an actual variant or a
false positive, while providing justification for its decision.
2. Variant Annotation and Filtering
Once I had identified the potential variants in a sample via MuTect, I used
ANNOVAR to annotate them (Wang, et al., 2010). These annotations identify
aspects of the mutation, such as where a variant is located on a gene (e.g., intron,
exon, intergenic) and which gene the variant affects, or the closest genes if the
variant is intergenic.
My criteria for selecting the variants used for the study are based on the
statistical information derived from MuTect’s results. Specifically, I filtered out any
variants that the caller has marked as unlikely to be a real mutation. I also filtered
out any variants that fell in the exonic regions of genes as identified by ANNOVAR,
since I wanted to primarily focus on mutations in the noncoding regions. In order to
further ensure the accuracy of the detected variants, I also filtered out those that
have a read depth of 30 or less. Finally, I removed variants that were not within
25,000 base pairs of an end of a gene. This filtering process was done via Python
scripts.

15

Figure 5. Areas of the DNA considered for analysis of noncoding variants.
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To further reduce the number of variants and to begin identifying any potential
associations, I restricted the list of genes based on the number of samples in which
the gene is mutated. I extracted the list of genes from the ANNOVAR results for
each sample, then constructed a table indicating whether a gene carried a mutation
in a particular sample. After totaling up the number of samples each gene is present
in, I considered only genes that have variants in at least 8 different samples. The set
of noncoding variants was then reduced to only those that affected one of the genes
in the list, or was near one of the genes if the variant was intergenic. The number of
variants at each step can be found in the Results section.

3. Functional RNA Motif Identification
Once I had finalized the set of noncoding variants, I began identifying the
functional RNA motifs that were affected by the variants. This was done using the
integrated web server for RegRNA 2.0 (Chang et al., 2013), which takes as input a
sequence of nucleotides of either DNA or RNA and outputs information on any
functional RNA motifs that were identified in the sequence. Due to limitations with
the RegRNA program, I could only analyze sequences of up to 10,000 base pairs at
a time. For sequences of that length, the program took up to a minute to analyze.
Therefore, I attempted to select the sequences such that as many variants as
possible would be covered with every scan. I used a Python script to evaluate the
mutations and identify sequences of 10,000 base pairs that covered the most
variants. In order to account for RNA motif sequences that begin before the
mutation’s position, the script set the start of the sequence for analysis at 200 base
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pairs before the mutation, which is a large enough buffer for the majority of possible
motifs. I then used the Python library mechanize, which allows a user to browse
web pages via Python, to input the sequence to RegRNA and obtain the output,
which were then stored for later analysis. In order to avoid overloading the RegRNA
server, I added a 45 second delay between requests.
RegRNA outputs are formatted as tab-delimited text-files with columns
indicating the motif type, the motif name, the range of bases, the length of the motif
sequence, and the sequence itself. Using this information, I determined the RNA
motifs affected by a particular variant by identifying the 10,000 base pair sequence
that contained the variant, then analyzing the matching file to get the data. I used a
Python script to scan each line of the file and identify the ones that contained the
variant’s position in the listed range of bases.

4. Identifying RNA motifs significantly affected by noncoding mutations
To identify RNA motifs enriched for mutations, I compared the motifs affected
by mutations against a background. The background data for this comparison
needed to be free from bias. I first attempted to use the RNA motif found in all of the
analyzed sequences as the background data. This, however, was biased, since the
analyzed sequences were based on the set of noncoding variants. Therefore, I
decided to instead randomly select segments of the genome that were within the
same bounds as those used to filter the variant sets. While this seemed to work
better as the background data set, I realized that it could be further improved by
selecting random locations on the noncoding segments. Specifically, I obtained the
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Figure 6. Pipeline for first specific aim
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genomic start and end positions for each gene and the positions of the gene’s exons
from the UCSC genome browser and randomly selected points such that the points
were within 25,000 base pairs of the end of a gene and did not lie in any gene’s
exonic regions. These points were defined as noncoding variants for the random
set. I then analyzed the sequences that cover these random points, therefore
providing us a background data set similar to our actual data.
In order to check for bias in the random selection, I independently generated
two different random sets of points using the criteria described previously. The
number of points in each set was approximately the same as the number of actual
noncoding variants. After I analyzed the points to find the motifs affected, I used a
2x2 contingency table for each motif to calculate the chi-squared significance
between the random sets of points. The columns of the tables totaled the number of
bases that were considered part of the first random set or the second random set,
while the rows totaled the number of bases that were part of the particular motif
sequence. I applied a Bonferroni correction and found that none of the motifs
showed any significant difference between the random sets. This indicated that the
selection process could generate background sets with similar properties.
To score the RNA motifs, I used the same technique. I constructed
contingency tables for each motif containing the counts of variants compared to one
of the random sets. I again applied a Bonferroni correction and evaluated which
motifs were significant. If a particular RNA motif was shown to be significant based
on the p-value of its chi-square score, then this indicated that the number of
mutations that affected that motif was significantly different from what would be
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expected at random. I also calculated the log-odds ratio for each motif, which gave
further information on the enrichment of variants affecting motifs in the variant set
relative to the background data. If the ratio was positive for a particular motif, this
indicated that there were more mutations affecting the motif in the breast cancer
samples than would be expected at random; conversely, if the ratio was negative,
then the motif had less mutations affecting it. I did these analyses for both of the
random sets that I had generated, which allowed me to check if the results were
consistent.

5. Regression analysis of motifs
Using the list of noncoding mutations and the affected RNA motifs, I
determined their functional significance by analyzing the pathway scores. As a
positive control, I used the coding variants in the analysis since I would expect those
variants to have a significant effect on cancer-related pathways. I obtained the
information for the KEGG cancer pathways from SigDB (Kanehisa et al., 2017;
Kanehisa et al., 2016; Kanehisa et al., 2000), which included the pathway names
and the genes that made up the pathways. In order to calculate a score for the
pathways, I also downloaded the file containing breast cancer gene expression
information from the Broad Firehose Pipeline (Broad Institute TCGA Genome Data
Analysis Center, 2016). This file consists of a table of genes that were analyzed for
their expression levels against TCGA breast cancer samples. Using an in-house
program, I calculated a score for each pathway based on the genes in the pathway
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Figure 7. Pipeline for second aim
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and their expression levels (Chang et al., 2011). I then constructed a simple linear
model in R using the pathway score as the response variable, while the explanatory
variables were selected based on the desired model. In order to ascertain the
effectiveness of the model, I first focused on the cell cycle pathway, which is known
to be a highly important pathway in cancer (Hartwell and Kastan, 1994). The first
model I constructed used only the coding mutations as the explanatory variables in
order to test whether they could have a significant effect on the cell cycle’s pathway
score, validating my approach. As shown in Table 2, the p-value indicates that the
coding mutations do indeed have a significant effect in determining the pathway
score. Once I had verified that the coding mutations contributed significantly in the
linear model, I constructed models to see if any of the motifs affected by noncoding
mutations could also have a significant effect on the score. To do this, I counted the
number of mutations that affected each motif in each sample. To account for the
fact that the number of mutations affecting a motif varied directly with the number of
mutations in the sample, I divided the number of mutations that affected a particular
motif by the total number of mutations affecting any motif in the sample, thus
calculating the proportion of all mutations affecting a specific motif. Using these
proportions as the explanatory variables, I constructed three models: the first

Variable Coefficient p-value
Coding

116.63

0.00379***

Table 2. Coefficient for a linear model with the coding mutations as
explanatory variables. ***P < 0.01
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consisting of all noncoding motifs, the second consisting of all noncoding motifs and
the coding mutations, and the last consisting only of those motifs found to be
significant in aim 1 plus the coding mutations.
Once I had evaluated the effects of the RNA motifs on the cell cycle pathway
score, I expanded my analysis to the other pathways in KEGG’s set of pathway.
Since the p-value for the model using only the significant RNA motifs and the coding
mutations was the most significant, I applied that model to the other pathways. After
calculating the coefficients, I used an in-house program to calculate the false
discovery rate (FDR) adjusted p-values for each of the pathways. I then pulled out
the five pathways with the most significant FDR adjusted p-value, which are listed in
Table 6. For each of these pathways, I identified the RNA motifs that were
significant for p < 0.05. This allowed me to identify if there were any patterns in
which biological processes defined by motifs were most commonly differentially
affected by noncoding mutations.
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RESULTS
1. Data Processed
I downloaded a total of 28 paired BRCA WGS files from the TCGA. Of the
samples, 2 came from the HMS-RK, while 26 came from the WUGSC. All of the
files were reprocessed as described in the Methods, then analyzed using MuTect.
After filtering out all variants that were rejected based on MuTect’s own criteria,
there was a total of 303,811 unique variants detected across all samples. After I had
annotated the variants with ANNOVAR, I separated them into the coding and
noncoding variants. This gave a total of 2,872 coding variants and 300,939
noncoding variants. Of the remaining noncoding variants, I filtered out those that did
not satisfy the criteria stated in the Methods section, leaving a total of 164,289
unique variants. Finally, when I considered only the genes that were affected by
noncoding variants in at least 8 samples, I obtained 1,981 unique genes, thereby
providing a total of 43,501 noncoding variants in the final set. 1,352 of these
variants were present in more than one sample, with 235 of them present in three or
more.
From the variants across all of the samples, I generated 17,507 sequences of
10,000 base pairs. Each sequence was passed through the RegRNA 2.0 web
server and analyzed for possible functional RNA motifs. Additionally, two
independent sets of randomly-selected points were generated as the background
data for comparison with the set of noncoding variants. The first set contained 7,163
points, while the second consisted of 7,154 points. An additional 5,171 sequences
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Abbreviation Full Motif Name
ncRNA hybridization
ncRNA
region

Abbreviation Full Motif Name
ESE

Exon splicing enhancer

longStems

Long stems

ESS

Exon splicing silencer

funcRNA

Functional RNA motifs

UTR

Untranslated region

miRNA

microRNA target sites

ERPIN

Cis-regulatory elements
of ERPIN

Splicing

Human splicing sites

ARE

AU-rich elements

Transcript
RIT

Transcriptional RNA
motifs
Rho-independent
terminator

PAS

Polyadenylation Sites

RBS

Ribosome binding sites

ISE

Intron splicing
enhancers

C2U

C-to-U RNA editing sites

ORF

Open reading frames

ISS

Intron splicing silencer

Table 3. Identified functional RNA motifs and name abbreviations.
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were analyzed via RegRNA to cover the random points. Table 1 lists the types of
motifs that were detected in the breast cancer samples and the random sets of
points, as well as the number of variants in each sample or random set that affected
the particular motif.

2. Significant RNA Motifs
Of the 19 functional RNA motifs that RegRNA can identify, 16 were affected
by at least one variant present in both the cancer samples and the randomly
generated points. Out of the 16 motifs, 8 were significantly differentially affected by
noncoding variants compared to the first random set. These motifs include
transcriptional regulatory motifs, exon splicing silencers, long stems, intron splicing
enhancers, microRNA target sites, functional RNA sequences, ncRNA hybridization
regions, and open reading frames. The same motifs were also significant when
compared to the second random set, though with the addition of exon splicing
enhancers, showing that the results were consistent. Additionally, when I compared
the log ratios between the variants and both random sets, I found that every
significant motif had a negative ratio, as shown in figure 8 for the first random set.
Figure 9 shows that the results are consistent for the second random set. What this
indicates is that in the cancer samples, those motifs are affected by fewer noncoding
variants than we would expect if the motifs had been affected at random. This
implies that the motifs may have a critical effect on the survival of cancer cells or
perhaps even all cells, including normal cells.
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Figure 8. Log-odds ratio between the variants set and the first random set with
chi-square significance. ***P < 0.01; **P < 0.05
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Figure 9. Comparison of log-odds ratios between variants set and first
random set and between variants set and second random set.
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It would be ideal to find out if the motifs bearing possible cancer-related
mutations might affect cancer prognosis by correlating their occurrence with the
survival rates of the patients. However, partially due to the low number of cancer
samples I have analyzed so far, it is difficult to construct a Kaplan-Meier curve that
displays any significance in survival.

3. Significant RNA motifs within a pathway remain constant
The coefficients and p-values for the linear model using all of the RNA motifs
affected by noncoding variants as explanatory variables are presented in Table 3.
Although the p-values for many of the RNA motifs are fairly weak, there are
nonetheless two motifs - the transcriptional regulatory motif and intron splicing
enhancer motif - that appear to have a significant effect on the cell cycle pathway
score, with p < 0.05. Notably, this also holds true for the model that includes all RNA
motifs plus the coding mutations and the model that includes only significant motifs
plus the coding mutations, which are presented in Table 4 and Table 5, respectively.
This suggests that these provide functionality unrelated to the mutations found in the
coding regions.

4. Splicing-related RNA motifs appear significant in cancer-related pathways
After applying the false discovery rate adjustment, I found that most of these
pathways do not have a significant p-value, with the lowest, the cell cycle pathway,
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Variable

Coefficient

p-value

Variable

Coefficient

p-value

ESE

-12.505

0.4587

ncRNA

-18.041

0.1132

ESS

-12.215

0.4553

longStems

-5.717

0.2068

UTR

-12.384

0.1321

funcRNA

22.893

0.0747*

ERPIN

3.292

0.7222

miRNA

-4.850

0.7024

Splicing

13.840

0.5727

Transcript

7.793

0.0555*

ARE

23.119

0.3135

RIT

6.999

0.5946

RBS

8.601

0.9421

PAS

-9.777

0.2195

C2U

-722.505

0.2838

ISE

-20.407

0.0203**

ISS

157.523

0.5929

ORF

1.738

0.6961

Table 4. Coefficient for a linear model with all noncoding motif proportions as
explanatory variables. *P < 0.1; **P < 0.05
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Variable

Coefficient

p-value

Variable

Coefficient

p-value

ncRNA

-15.495

0.1792

ESS

-9.508

0.5642

longStems

-6.325

0.1717

UTR

-12.380

0.1343

funcRNA

22.468

0.0818*

ERPIN

-5.606

0.6620

miRNA

-7.388

0.5699

Splicing

11.275

0.6466

Transcript

9.693

0.0393**

ARE

9.667

0.7110

RIT

3.501

0.7956

RBS

-8.574

0.6428

PAS

-8.429

0.2930

C2U

-736.873

0.2762

ISE

-24.157

0.0165**

ISS

87.914

0.7701

ORF

1.351

0.7617

Coding

80.586

0.3263

ESE

-18.363

0.3114

Table 5. Coefficient for a linear model with all noncoding motif proportions
and coding mutations as explanatory variables. *P < 0.1; **P < 0.05

32

Variable

Coefficient

p-value

Variable

Coefficient

p-value

ncRNA

-14.3670

0.1036

ISE

-14.0437

0.0220**

longStems

-0.6398

0.7900

ORF

-1.5679

0.5791

funcRNA

11.9822

0.1496

ESE

-10.5800

0.3020

miRNA

7.3640

0.3960

ESS

-6.5410

0.4637

Transcript

4.0052

0.0567*

Splicing

-3.0343

0.8299

RIT

-1.9769

0.8532

Coding

20.9997

0.6337

Table 6. Coefficient for a linear model with significant noncoding motif
proportions and coding mutations as explanatory variables. *P < 0.1; **P < 0.05
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having a p-value of 0.09. Nonetheless, using this list, we can rank the motifs that
may significantly affect individual or multiple cancer pathways. From these
analyses, I noticed that the intron splicing enhancers are not only associated with
the cell cycle pathway but also appear to affect other pathways, including the
dorsoventral axial pathway and the progesterone mediated oocyte maturation
pathway. Similarly, motifs such as the exon splicing enhancers and exon splicing
silencers appear to affect the score of at least one of the pathways. Thus, in almost
all of these pathways, I detected a splicing-related motif that has a significant effect
on the pathway score. This suggests that the splicing-related motifs may have a key
role in the relation between noncoding mutations and cancer.
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Pathway

FDR-adjusted
Equation p-value

Significant Motifs (p < 0.05)

Cell Cycle

0.09423408

Transcript, ISE

Dorsoventral Axial
Formation

0.09423408

ncRNA, longStems, RIT,
funcRNA, ESE, ISE, Coding

Pathogenic E. Coli
Infection

0.10729589

RIT, ESS

Progesterone Mediated
Oocyte Maturation

0.14094723

ncRNA, Transcript, ESE,
ESS, ISE

Taste Transduction

0.16675849

Splicing, longStems, miRNA,
ESS

Table 7. Table of pathways with the lowest equation p-values after FDR
correction and their significant motifs.
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CONCLUSIONS
1. Discussion
I developed computational methods to identifying noncoding mutations that
may impact cancer development. In this study, I analyzed whole genome
sequencing data for 28 breast cancer patients. Based on the analysis, I identified a
number of functional RNA motifs that carried a significantly different number of
mutations compared to what would be expected at random. As noted previously,
much of cancer mutation research has focused on the relation between coding
mutations and cancer; thus, by focusing on identifying functional RNA motifs that are
significantly differentially affected by noncoding mutations, I have taken steps to
clarify the connection between these mutations and cancer. Furthermore, I
conducted additional analyses correlating the noncoding mutations with cancerrelated pathways. From this, I observed that splicing-related motifs may have a
large impact on function. This indicates that previous methods that have focused
primarily on transcriptional elements have missed a large portion of the genome that
is enriched for possible drivers. These findings suggest that the current analysis
may be useful for identifying regions of the genome that are significant to cancer
development based on function RNA motifs.
A number of interesting observations were made from this study. First,
noncoding mutations in splicing-related functional RNA motifs, including intron
splicing enhancers, exon splicing silencers, and exon splicing enhancers were
significantly linked to breast cancer. More importantly, these types of motifs were
consistently found to be significantly associated with cancer-related pathways, such
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as the cell cycle pathway, indicating that they are functional. This finding is strongly
supported since splicing errors can lead to early termination, alternative splicing, and
instability of the mRNA, rendering loss of expression or changes in the function of
the proteins that play critical roles in the cancer-related pathways. Recently, it was
reported that, based on RNA sequencing data, alternative exon usage was widely
present in breast cancer samples and that some of the alternatively spliced products
are specific to breast cancer subtypes (Bjørklund et al., 2017). Therefore,
alternative splicing can be crucial contributors to oncogenesis and specific splicing
events on specific genes may be associated with particular breast cancer subtypes.
This is consistent with the finding presented here that mutations on splicing-related
RNA motifs are associated with breast cancer. Similarly, transcriptional regulatory
motifs are also important for producing mRNAs, which in turn produce protein
products. Mutations in these motifs will likely alter protein expression and thereby
impact cancer development. Indeed, I found that noncoding mutations in the
transcriptional regulatory motifs tended to be associated with the cell cycle pathway,
though the p-value is borderline significant.
Second, I found that in regions predicted to affect RNA processing that the
number of mutations detected in the tumor samples was less than would be
expected at random. This suggests that these motifs are less tolerant toward
mutations relative to other regions. One potential explanation is that these motifs
are critical to cell survival such that genetic variations are detrimental to the cell.
This could be specific to cancer cells or possibly healthy cells in general. To
distinguish between these possibilities, we would need to examine genetic variations
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in these motifs in normal cell samples. If these motifs also carry fewer variants in
normal samples, then they are likely to be crucial toward general cell survival. On
the other hand, if the motifs are negatively enriched by noncoding mutations only in
the cancer samples, then those motifs may be specifically important for supporting
cancer growth.
Third, I observed that certain cancer-related pathways appeared to be
significantly associated with particular identified significant motifs in breast cancer,
such as the KEGG cancer pathways and the ISE and transcriptional regulatory
motifs. The reason for this is not clear. One possibility is that the specific functions
defined by the motifs are particularly crucial for RNA processing, transcriptional
regulation, or other functions of at least one gene in the pathway. In this case, there
may be specific motifs that bear recurrent mutations, while the affected genes play
critical roles in the pathway’s function. Detailed examination of the motifs with
recurrent mutations in all samples would help to clarify the situation. Alternately, it is
also possible that certain pathways just contain more genes compared to other
pathways, which would then affect cell growth and proliferation when mutated.
Finally, due to the small sample size of the study, its statistical power is limited,
which means that some of the observed associations may be random. Increasing
the sample size would likely improve the quality of the analysis and help verify
validity of the associations.

2. Future Directions
There are a number of improvements that can be made to this study. Among
them, the most important task would be to obtain more samples from the TCGA
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database, which would increase the power of our statistics. Currently, we have
analyzed 28 samples of the 118 whole genome samples available for breast cancer
from the TCGA. Additionally, other projects have generated more data featuring
WGS analysis, such as the ICGC PanCancer Analysis of Whole Genomes
(PCAWG) study. Having more breast cancer samples would also allow us to
categorize them by different subtypes, which could uncover more specific
mechanisms of noncoding mutations. These mechanisms may also be clarified by
analyzing the motifs by name (e.g., eukaryotic-type signal recognition particle),
rather than type (e.g. functional RNA sequences), which can better identify the
specific RNA processes that are significantly associated with noncoding mutations.
Various improvements can be made to the filters and algorithms used
throughout the study, which would allow us to improve and verify the data and thus
our conclusions. For example, using other callers aside from MuTect would allow us
to cross-check the results, thus improving the accuracy of detected mutations.
Adjusting the filters that define the set of noncoding mutations would allow us to
identify relevant mutations more reliably. While the method for generating the
background data in Aim 1 accounts for the location-based filters of the noncoding
mutations, it does not consider the other filters such as the minimum read depth,
which may introduce a bias because of how the read depth can be affected by things
such as GC content. Failing to take this filter into account may cause the random
selection to select regions of the genome that are underrepresented among the
actual variants. It may also be appropriate to explore alternate models for the
regression analysis in Aim 2. Developing a different linear or nonlinear model may
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improve the analysis and give more insight into which pathways are strongly
impacted by the presence of noncoding mutations on RNA motifs. Finally, we could
analyze pathways from sources other than KEGG to get more information on the
functional impact of noncoding mutations.
Based on the results of the study, splicing-related motifs appear to be the
most significant when affected by noncoding mutations in the context of cancer.
These results can be verified by analyzing the samples that were not used in this
study and checking if the findings are consistent. The presence of splicing-related
motifs can also be checked by analyzing RNA-seq data to verify if alternative
splicing can be found in predicted areas. If splicing-related motifs remain relevant
after verification, then the next step would be to further investigate the recurrence of
alternative splicing in tumor samples and their importance to cancer development.
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APPENDIX
1. Scripts
1.1 runbetsy.sh
Runs Betsy on chosen folder (caseNum). Multiple BAM files from different
samples can be processed at once. Tumor samples should be named
tumor.case##.bam with matched normals named normal.case##.bam.
Processing tasks include realigning via BWA-MEM, marking duplicates, checking for
read groups, realigning indels, sorting by coordinates, and indexing folders.
1.2 runMutect.sh
Runs MuTect on selected files. Tumor sample should be named
tumor.case##.bam with matched normal named normal.case##.bam. To
analyze a sample more quickly, the script is run per chromosome in parallel.
1.3 procGenes.sh
Processes MuTect output and annotates identified mutations via ANNOVAR.
Outputted files will also include information from the MuTect output, such as read
depth and MuTect’s judgment on the variant.
1.4 variantFilter.py
Filters variants based on criteria as listed in the Methods section. Additionally
separates the variants into coding and noncoding.
1.5 variantGet.py
Generates a hash for variants from ANNOVAR output files. Hashes are
generated from the chromosome, reference allele, alternate allele, and location of
the variant.
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1.6 run_regrna.py
Processes DNA sequences through the RegRNA 2.0 web program. The
mechanize library for Python is used to access the web. Results for each sequence
are stored by chromosome. The script then identifies the RNA motifs affected by
each variant from a list and outputs them to a file. The table consisting of the
number of variants affecting a particular motif for each sample can be created.
1.7 hgTables_slim.py
Generates a random set of locations for the background data in Aim 1. Genome
and gene information is taken from the UCSC Genome Browser. Valid segments
are selected based on criteria used for selecting variants (e.g., non-exonic, location
< 25,000 bps from the end of a gene). Random points are then uniformly randomly
selected from all valid positions.
1.8 regression2.R
Conducts linear regression on coding and noncoding mutations relative to the
pathway score, as described in Methods for Aim 2.
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1.1 runbetsy.sh
#!/bin/bash
caseNum=case28
refFile=hsa19/Homo_sapiens_assembly19.fasta
A=Mills_and_1000G_gold_standard
python ~/changlab/Betsy/scripts/betsy_run.py
--network_png ~/${caseNum}_network.png
--input BamFolder --input_file ~/data/$caseNum/bamfiles/
--dattr BamFolder.aligner=bwa_mem
--input ReferenceGenome --input_file ~/data/$refFile
--output BamFolder
--output_file ~/data/$caseNum/bamfile_proc/
--dattr BamFolder.aligner=bwa_mem
--dattr BamFolder.duplicates_marked=yes
--dattr BamFolder.has_read_groups=yes
--dattr BamFolder.indel_realigned=yes
--dattr BamFolder.sorted=coordinate
--dattr BamFolder.indexed=yes
--dattr BamFolder.base_quality_recalibrated=yes
--mattr realign_known_sites1=~/v/$A.indels.hg19.sites.vcf.gz
--mattr
realign_known_sites2=~/v/1000G_phase1.indels.hg19.sites.vcf
.gz
--mattr recal_known_sites1=~/v/$A.indels.hg19.sites.vcf.gz
--mattr
recal_known_sites2=~/v/1000G_phase1.indels.hg19.sites.vcf.g
z
--mattr recal_known_sites3=~/v/dbsnp_138.hg19.vcf.gz
--num_cores 40 –run
1.2 runMutect.sh
#!/bin/bash
caseNum=28
thisCase=case$caseNum
mkdir ~/data/$thisCase/processed
samtools idxstats
~/data/$thisCase/bamfile_proc/tumor.$thisCase.bam |
cut -f 1 > ~/data/$thisCase/processed/listChr.txt
i=1

43

thisChr=$(sed "$i"'q;d'
~/data/$thisCase/processed/listChr.txt)
flag=true
fileString=~/data/$thisCase/processed/chr$thisChr.out
while [ "$flag" = true ] && [ $i -lt $(wc -l
~/data/$thisCase/processed/listChr.txt | cut -f 1 -d ' ') ]
do
if [ -f $fileString ]
then
((i++))
thisChr=$(sed "$i"'q;d'
~/data/$thisCase/processed/listChr.txt)
fileString=~/data/$thisCase/processed/chr$thisChr.out
else
flag=false
fi
done
if [ $i -lt $(wc -l ~/data/$thisCase/processed/listChr.txt |
cut -f 1
-d ' ') ]
then
java -Xmx2g -jar ~/data/mutect-src/mutect/target/mutect1.1.7.jar
--analysis_type MuTect
--reference_sequence
~/data/hsa19/Homo_sapiens_assembly19.fasta
--cosmic ~/data/b37_cosmic_v54_120711.vcf
--dbsnp ~/data/dbsnp_132_b37.leftAligned.vcf
--intervals $thisChr
--input_file:normal
~/data/$thisCase/bamfile_proc/normal.$thisCase.bam
--input_file:tumor
~/data/$thisCase/bamfile_proc/tumor.$thisCase.bam
--out $fileString
fi
1.3 procGenes.sh
#!/bin/bash
for i in 28
do
caseNum=case$i
caseFold=~/data/$caseNum/processed/info
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cat ~/data/$caseNum/processed/chr* >
~/data/mutectFull/out.$caseNum.out
rm ~/data/$caseNum/processed/chr*
cut -f 1,2 ~/data/mutectFull/out.$caseNum.out >
~/data/$caseNum/processed/part1
cut -f 2 ~/data/mutectFull/out.$caseNum.out >
~/data/$caseNum/processed/part2
cut -f 4,5,16,26,27,38,39,51
~/data/mutectFull/out.$caseNum.out >
~/data/$caseNum/processed/part3
mkdir ~/data/$caseNum/processed/info
paste ~/data/$caseNum/processed/part1
~/data/$caseNum/processed/part2
~/data/$caseNum/processed/part3 >
~/data/$caseNum/processed/info/$caseNum.anvinput
rm ~/data/$caseNum/processed/part*
~/data/mutect-src/annovar/annotate_variation.pl
-out ~/data/$caseNum/processed/info/$caseNum.anvoutput
-build hg19
~/data/$caseNum/processed/info/$caseNum.anvinput
~/data/mutect-src/annovar/humandb
echo $caseNum complete
Done
1.4 variantFilter.py
import sys
import os
for i in range(28):
thisCase = 'case' + str(i+1)
fCase = open('data/' + thisCase + '/processed/info/' +
thisCase + '.anvoutput.variant_function')
codMuts = []
regMuts = []
for line in fCase:
lineList = line.split('\t')
if lineList[12].strip() == "KEEP" and
int(lineList[7].strip())>30:
mutType = [x.strip() for x in
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lineList[0].split(';')]
geneNom = lineList[1].strip()
if "exonic" in mutType:
codMuts.append(line)
elif "intergenic" in mutType:
if ',' in geneNom:
interGenes = geneNom.split(',')
distList = []
for aGene in interGenes:
temp =
aGene[aGene.find('=')+1:aGene.find(')
')]
if "NONE" not in temp:
distList.append(int(temp))
if any([x < 25000 for x in distList]):
regMuts.append(line)
else:
regMuts.append(line)
fCodOut = open('data/' + thisCase + '/processed/info/' +
thisCase + ".codMuts.filtered.txt", 'w')
for line in codMuts:
fCodOut.write(line)
fRegOut = open('data/' + thisCase + '/processed/info/' +
thisCase + ".regMuts.filtered.txt", 'w')
for line in regMuts:
fRegOut.write(line)
1.5 variantGet.py
import sys
import os
for i in range(28):
thisCase = 'case' + str(i+1)
fCase = open('data/' + thisCase + '/processed/info/' +
thisCase + '.regMuts.filtered.txt')
varList = []
for line in fCase:
lineList = line.split('\t')
mutChr = lineList[2].strip()
mutLoc = lineList[3].strip()
mutRef = lineList[5].strip()
mutAlt = lineList[6].strip()
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varList.append(mutChr + mutRef + mutAlt + mutLoc)
fOut = open('data/' + thisCase + '/processed/info/' +
thisCase + '.regVars.txt', 'w')
for aVar in varList:
fOut.write(aVar + '\n')
1.6 run_regrna.py
import sys, os
import re
from urllib2 import HTTPError
import mechanize
from genomicode import genomelib
import random, time, shutil
assert mechanize.__version__ >= (0,0,6,"a")
def readRegions(thisType='real'):
if thisType == 'fake':
fOpen=open('fakeRegionsCovered.txt')
else:
fOpen = open('regionsCovered.txt')
header = fOpen.readline()
chrDict = {}
for line in fOpen:
lineList = line.split('\t')
thisChr = lineList[0].strip()
thisPos = int(lineList[1].strip())
thisLen = int(lineList[2].strip())
if thisChr not in chrDict:
chrDict[thisChr] = []
chrDict[thisChr].append((thisPos, thisLen))
fOpen.close()
return chrDict
def updateChrDict():
global gloChrDict
gloChrDict = readRegions()
def getPos(pos):
if list(pos)==pos:
return pos
else:
thisLen = 0
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if '.' in pos:
tempPos = pos.split('.')
thisChr = tempPos[0]
thisPos = tempPos[1]
if len(tempPos)>2:
thisLen = tempPos[2]
else:
thisChr = pos[0:2]
thisPos = pos[4:]
if any(x in thisChr for x in ['A', 'T', 'C', 'G',
'N']):
thisChr = pos[0:1]
thisPos = pos[3:]
return [thisChr, thisPos, thisLen]
def fillForm(mech, fasta):
mech.select_form(nr=0)
mech['S1']=fasta
mech['tfbs'] = ['ON']
mech['SplicingSite']=['ON']
mech['SplicingMotif']=['ON']
mech['Polya']=['ON']
mech['RBSfinder']=['ON']
mech['rho']=['ON']
mech['UTRsite']=['ON']
mech['AUrich']=['ON']
mech['RNAediting']=['ON']
mech['RiboSW']=['ON']
mech['ERPIN']=['ON']
mech['Rfam']=['ON']
mech['LongStem']=['ON']
mech['fRNAdb']=['ON']
mech['miRNA']=['ON']
mech['ncRNA']=['ON']
mech['GCratio']=['ON']
mech['accessibility']=['ON']
return mech
def fillFormFix(pos, ball):
mech = setupBrowser()
mech.select_form(nr=0)
thisFa = generateFa(pos, ball)
mech['S1']=thisFa
mech['SplicingSite']=['ON']
mech['SplicingMotif']=['ON']
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mech.submit()
print "Form fix submitted"
tempList = thisFa.split('\n')
fileNom=tempList[0][1:]
urls = [link.absolute_url for link in
mech.links(url_regex=re.compile('\.all\.result'))]
url = urls[0]
filename='/home/kzhu/data/RegRNA/regrna_resultstemp/'+fileN
om+'.txt'
f=open(filename, 'wb')
print filename
r = mech.open(url)
while 1:
data = r.read(1024)
if not data: break
f.write(data)
f.close()
if checkIfFileExists(fileNom, 'min'):
f=open(filename, 'r')
fOut = open('/home/kzhu/data/RegRNA/regrna_results/' +
fileNom + '.txt', 'a')
for line in f:
if any([x in line for x in ['(ESE)', '(ESS)',
'(ISE)', '(ISS)']]):
fOut.write(line)
fOut.close()
f.close()
os.remove(filename)
def tempRun():
#fixes an error from a previous RegRNA run
fixedList = []
fOpen = open('fixedList.txt')
for line in fOpen:
fixedList.append(line.strip())
fOpen.close()
fOpen = open('fixedList.txt', 'a')
fiList = os.listdir('regrna_results')
for i in fiList:
if i not in fixedList:
fillFormFix(i.strip('.txt'), 10000)
fOpen.write(i + '\n')
fixedList.append(i)
print 'Fix complete. Waiting 30 seconds...'
time.sleep(30)
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fOpen.close()
def generateFa(pos='', ball=10000):
thisPos = getPos(pos)
thisChr = thisPos[0]
thisStart = thisPos[1]
thisLen = int(thisPos[2]) if (int(thisPos[2])>0) else ball
thisSeq = genomelib.get_sequence(thisChr, int(thisStart),
int(thisLen))
thisOut = '>' + thisChr + '.' + thisStart + '.' +
str(thisLen)
counter = 0
for i in thisSeq:
if counter % 50 == 0:
thisOut += '\n'
thisOut +=i
counter +=1
return thisOut
def setupBrowser():
regrna = mechanize.Browser()
regrna.set_handle_robots(False)
try:
regrna.open("http://regrna2.mbc.nctu.edu.tw/detection.h
tml")
except HTTPError, e:
return ''
return regrna
def fillAndSub(pos='', ball=10000):
thisFa = generateFa(pos, ball)
temp = setupBrowser()
if temp:
mech = fillForm(temp, thisFa)
mech.submit()
print "Form Submitted"
tempList = thisFa.split('\n')
fileNom = tempList[0][1:]
urls=[link.absolute_url for link in
mech.links(url_regex=re.compile(r"\.all\.result"))
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]
url = urls[0]
filename =
'/home/kzhu/data/RegRNA/regrna_resultstemp/'+fileNom
+'.txt'
f=open(filename, 'wb')
print filename
r=mech.open(url)
while 1:
data=r.read(1024)
if not data: break
f.write(data)
f.close()
else:
f = open('redo.txt', 'a')
f.write(pos + '\n')
f.close()
def checkIfCovered(pos):
thisPos = getPos(pos)
thisChr = thisPos[0]
thisStart = str(thisPos[1])
thesePos = gloChrDict[thisChr]
isCov = any( [int(thisStart) >= (x[0]+200) and
int(thisStart) <= (x[0]+x[1]-200) for x in thesePos] )
return isCov
def getCover(pos):
thisPos = getPos(pos)
thisChr = thisPos[0]
thisStart = thisPos[1]
thesePos = gloChrDict[thisChr]
findCov = [int(thisStart) >= (x[0]+200) and int(thisStart)
<= (x[0]+x[1]-200) for x in thesePos]
thisInd = findCov.index(True)
thisVal = thesePos[thisInd]
thisHash = thisChr + '.' + str(thisVal[0]) + '.' +
str(thisVal[1])
return thisHash
def checkIfFileExists(aHash, level="full"):
theseFiles = os.listdir('regrna_results')
if level=='full':
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theseFiles.extend(os.listdir('regrna_resultstemp'))
return ((aHash+'.txt') in theseFiles)
def runTest():
fOpen = open('fakePosList4.reg.txt')
posList = []
for line in fOpen:
posList.append(line.strip())
fOpen.close()
blackList = ['7.158122530.10000', '14.19281652.10000',
'14.19293547.10000', '19.6769083.10000',
'14.19262029.10000', '14.19307662.10000',
'14.19292736.10000', '14.19272995.10000',
'14.19307640.10000', '14.19292291.10000']
#certain segments will cause RegRNA to stall (not sure why).
for simplicity, just ignore them
for i in posList:
if i and checkIfCovered(i):
thisHash = getCover(i)
if not checkIfFileExists(thisHash) and not thisHash
in blackList:
print i, thisHash, checkIfFileExists(thisHash)
fillAndSub(thisHash)
time.sleep(30)
def updateMotif():
fPosList = open('checkedResults.txt', 'r')
###checklist to avoid reexamining sequences
checkList = []
for line in fPosList:
checkList.append(line.strip())
fPosList.close()
fPosList = open('checkedResults.txt', 'a')
theseFiles = os.listdir('regrna_results')
###Obtain list of files containing results for analyzed
###sequences
chrMotList = os.listdir('motifInfo')
############################### filtering lists for
categorizing
fRan = open('adjRandomPosListAll.txt')
header = fRan.readline()
randList = []
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for line in fRan:
randList.append(line.strip().replace('\t', '.'))
fRan.close()
fFake = open('fakeRegionsCovered.txt')
header = fFake.readline()
fakeList = []
for line in fFake:
fakeList.append(line.strip().replace('\t', '.'))
fFake.close()
fFake2 = open('fakeRegionsCovered2.txt')
header = fFake2.readline()
fake2List = []
for line in fFake2:
fake2List.append(line.strip().replace('\t', '.'))
fFake2.close()
################################### end filtering lists
for i in theseFiles:
if i not in checkList:
aList =
thisChr
thisPos
thisLen
thisSeq

i.split('.')
= aList[0]
= aList[1]
= aList[2]
= 'variant'

if i in [x + '.txt' for x in randList]:
thisSeq = 'random'
elif i in [x + '.txt' for x in fakeList]:
thisSeq = 'gene-based'
elif i in [x + '.txt' for x in fake2List]:
thisSeq = 'gene-based2'
outFile = 'chr' + thisChr + '.txt'
if outFile not in chrMotList:
fOut = open('motifInfo/' + outFile, 'w')
fOut.write('Chromosome\tStart
Position\tSequence
Type\tLength\tMotif Type\tMotif
Name')
fOut.close()
chrMotList.append(outFile)
fOut = open('motifInfo/' + outFile, 'a')
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fOpen = open('regrna_results/' + i)
header = fOpen.readline()
print i
for line in fOpen:
if line.strip():
lineList = line.split('\t')
motType = lineList[0].strip()
motNom = lineList[1].strip()
motPos = lineList[2].strip()
posSplit = motPos.split('~')
motStart = int(posSplit[0].strip())-1
motLen = int(posSplit[1].strip())-motStart
thisStr = '\n' + thisChr + '\t' +
str(int(thisPos) + motStart) +
'\t' + thisSeq + '\t' +
str(motLen) + '\t' + motType +
'\t' + motNom
fOut.write(thisStr)
fOpen.close()
fOut.close()
checkList.append(i)
fPosList.write(i + '\n')
fPosList.close()
def motPurge():
fiList = os.listdir('motifInfo')
for i in fiList:
os.remove('motifInfo/' + i)
fRes = open('checkedResults.txt', 'w')
fRes.close()
def addToPosList(pos):
global gloChrDict
thisPos = getPos(pos)
thisChr = str(thisPos[0])
thisStart = str(thisPos[1])
thisLen = int(thisPos[2]) if (int(thisPos[2]) > 0) else
10000
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fOpen = open('regionsCovered.txt', 'a')
if thisChr not in gloChrDict:
gloChrDict[thisChr] = []
gloChrDict[thisChr].append((int(thisStart), thisLen))
fOpen.write('\n' + thisChr + '\t' + thisStart + '\t' +
str(thisLen))
fOpen.close()
def addTrueRandom(aNum):
i = 0
while i < aNum:
thisPos = getPos('')
while checkIfCovered(thisPos):
thisPos = getPos('')
i+=1
addToPosList(thisPos)
def addAdjRandom(aNum):
randChr = [random.choice(gloChrDict.keys()) for i in
range(aNum)]
fOut = open('adjRandomPosList5.txt', 'w')
fOut.write('Chromosome\tStart Position\tLength')
for i in randChr:
posList = [x[0] for x in gloChrDict[i]]
randPos = random.choice(posList)
thisPos = []
while not thisPos:
posA = [(i+'.'+str(randPos-11000+x)+'.10000') for x
in [-200, 0, 200]]
posB = [(i+'.'+str(randPos+11000+x)+'.10000') for x
in [-200, 0, 200]]
tempPos = [any([checkIfCovered(x) for x in posA]),
any([checkIfCovered(x) for x in posB])]
if not any(tempPos):
thisPos = random.choice([posA[1], posB[1]])
elif not all(tempPos):
thisPos = posB[1] if tempPos[0] else posA[1]
else:
randPos = random.choice(posList)
thisPos = []
addToPosList(thisPos)
thisPos = getPos(thisPos)
fOut.write('\n' + i + '\t' + str(thisPos[1]) + '\t' +
str(thisPos[2]))
fOut.close()
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def runRandTest():
fOpen = open('adjRandomPosListAll.txt')
header = fOpen.readline()
posList = []
for line in fOpen:
lineList = line.split('\t')
posList.append(lineList[0].strip() + '.' +
lineList[1].strip() + '.' + lineList[2].strip())
fOpen.close()
for i in posList:
if not checkIfFileExists(i):
fillAndSub(i)
def posScan(pos, mType='mut', motDict=''):
thisPos = getPos(pos)
thisChr = thisPos[0]
thisStart = int(thisPos[1])
chrFile = 'chr' + thisChr + '.txt'
existFiles = os.listdir(mType + 'Motifs/')
if checkIfCovered(thisPos) and chrFile in
os.listdir('motifInfo') and not (pos+'.txt' in
existFiles):
thisHash = getCover(thisPos)
if checkIfFileExists(thisHash, 'min'):
fOut = open(mType + 'Motifs/' + pos + '.txt', 'w')
fOut.write('Name\tChromosome\tStart Position\tMotif
Type\tMotif Names')
strPrefix = '\n' + pos + '\t' + thisChr + '\t' +
str(thisStart)
if not motDict:
varMots = procChrMotifs(chrFile)
else:
varMots = motDict[thisChr]
for aType in varMots.keys():
for aStart in varMots[aType].keys():
isCov = [thisStart >= int(aStart) and
thisStart <= (int(aStart) + x[0])
for x in varMots[aType][aStart]]
if any(isCov):
indList = [x for x,val in
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enumerate(isCov) if val]
for i in indList:
thisStr = strPrefix + '\t' + aType
+ '\t'
for motNom in [x[1] for x in
varMots[aType][aStart]]:
thisStr += motNom + ';'
thisStr = thisStr.strip(';')
fOut.write(thisStr)
fOut.close()
def posScanAll():
motDict = gloMotDict
print(motDict.keys())
mutPosList = []
fPos = open('poslist3.txt')
for line in fPos:
if line.strip():
mutPosList.append(line.strip())
fPos.close()
fakePosList = []
fFake = open('fakePosList.reg.buffer.txt')
for line in fFake:
fakePosList.append(line.strip())
fFake.close()
fake2PosList = []
fFake2 = open('fakeMutList4.txt')
for line in fFake2:
fake2PosList.append(line.strip())
fFake2.close()
fake3PosList = []
fFake3 = open('fakeMutList.fakeonly.reg.txt')
for line in fFake3:
fake3PosList.append(line.strip())
fFake3.close()
fakeIIPosList = []
fFakeII = open('fakePosList2.reg.txt')
for line in fFakeII:
fakeIIPosList.append(line.strip())
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fFakeII.close()
fake4PosList = []
fFake4 = open('fakePosList4.reg.txt')
for line in fFake4:
fake4PosList.append(line.strip())
fFake4.close()
if 0:
for i in mutPosList:
temp = getPos(i)
thisChr = temp[0]
if thisChr not in motDict:
motDict[thisChr] = procChrMotifs('chr' +
thisChr + '.txt')
posScan(i, 'mut', motDict)
print('Variants completed')
else:
print('Variants skipped')
if 0:
for i in fakePosList:
temp = getPos(i)
thisChr = temp[0]
if thisChr not in motDict:
motDict[thisChr] = procChrMotifs('chr' +
thisChr + '.txt')
posScan(i, 'fake', motDict)
print('Random A completed')
else:
print('Random A skipped')
if 0:
for i in fake2PosList:
temp = getPos(i)
thisChr = temp[0]
if thisChr not in motDict:
motDict[thisChr] = procChrMotifs('chr' +
thisChr + '.txt')
posScan(i, 'fake2', motDict)
print('Random B completed')
else:
print('Random B skipped')
if 0:
for i in fake3PosList:
temp = getPos(i)
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thisChr = temp[0]
if thisChr not in motDict:
motDict[thisChr] = procChrMotifs('chr' +
thisChr + '.txt')
posScan(i, 'fake3', motDict)
print('Random C completed')
else:
print('Random C skipped')
if 0:
for i in fakeIIPosList:
temp = getPos(i)
thisChr = temp[0]
if thisChr not in motDict:
motDict[thisChr] = procChrMotifs('chr' +
thisChr + '.txt')
posScan(i, 'fakeII', motDict)
print('Random D completed')
else:
print('Random D skipped')
if 1:
for i in fake4PosList:
temp = getPos(i)
thisChr = temp[0]
if thisChr not in motDict:
motDict[thisChr] = procChrMotifs('chr' +
thisChr + '.txt')
posScan(i, 'fake4', motDict)
print('Random E completed')
else:
print('Random E skipped')
def procChrMotifs(aFile, seqMat=False):
fOpen=open('motifInfo/' + aFile)
header = fOpen.readline()
motDict = {}
for line in fOpen:
if line.strip():
lineList = line.split('\t')
thisChr = lineList[0].strip()
thisStart = int(lineList[1].strip())
thisLen = int(lineList[3].strip())
thisType = lineList[4].strip()
thisNom = lineList[5].strip()
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thisSeq = lineList[2].strip()
if seqMat:
if thisSeq not in motDict:
motDict[thisSeq] = {}
if thisType not in motDict[thisSeq]:
motDict[thisSeq][thisType] = {}
if thisStart not in motDict[thisSeq][thisType]:
motDict[thisSeq][thisType][thisStart] = []
motDict[thisSeq][thisType][thisStart].append((t
hisLen, thisNom))
else:
if thisType not in motDict:
motDict[thisType] = {}
if thisStart not in motDict[thisType]:
motDict[thisType][thisStart] = []
motDict[thisType][thisStart].append((thisLen,
thisNom))
fOpen.close()
return motDict
def arrangeSegs(segList):
segList.sort(key=lambda x: x[0])
tempList = []
tempTup = (0,0)
for i in segList:
if i[0] > sum(tempTup):
if not tempTup[1] == 0:
tempList.append(tempTup)
tempTup = i
elif sum(i) > sum(tempTup):
thisLen = (i[0] - tempTup[0]) + i[1]
tempTup = (tempTup[0], thisLen)
return tempList
def motBaseInfo(aMot=''):
fiList = os.listdir('motifInfo')
chrList = filter(lambda x: 'chr' in x, fiList)
motDict = {}
for aChr in chrList:
thisDict = procChrMotifs(aChr, True)
thisChr = aChr.strip('.txt').strip('chr')
for seqType in thisDict.keys():
60

if seqType not in motDict:
motDict[seqType] = {}
chrDict = thisDict[seqType]
if not aMot:
for i in chrDict.keys():
if i not in motDict[seqType]:
motDict[seqType][i] = {}
tempMots = []
tempTup = (0,0)
thesePos = chrDict[i].keys()
thesePos.sort(key=int)
for j in thesePos:
tempLen = max([x[0] for x in
chrDict[i][j]])
if j > sum(tempTup):
if not tempTup[1] == 0:
tempMots.append(tempTup)
tempTup = (j, tempLen)
else:
thisLen = (j - tempTup[0]) +
tempLen
#start position of new section minus start position of
existing plus length of new section
tempTup = (tempTup[0], thisLen)
motDict[seqType][i][thisChr] = tempMots
elif aMot in chrDict.keys():
aMotDict = chrDict[aMot]
tempList = []
dummy = [tempList.extend(y) for y in
[aMotDict[x] for x in aMotDict.keys()]]
motNomList = [x[1] for x in tempList]
motNomList = list(set(motNomList))
for i in motNomList:
thesePos = filter(lambda x: any([y[1]==i
for y in aMotDict[x]]),
aMotDict.keys())
thesePos.sort(key=int)
if i not in motDict[seqType]:
motDict[seqType][i]={}
tempMots = []
tempTup = (0,0)
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for j in thesePos:
tempLen = max([x[0] for x in
filter(lambda y: y[1]==i,
aMotDict[j])])
if j > sum(tempTup):
if not tempTup[1] == 0:
tempMots.append(tempTup)
tempTup = (j, tempLen)
else:
thisLen = (j - tempTup[0]) +
tempLen
tempTup = (tempTup[0], thisLen)
motDict[seqType][i][thisChr] = tempMots
tempList = [str(x) for x in range(1,23)]
tempList.append('X')
lenDict = {}
strDict = {}
for seqType in motDict.keys():
lenDict[seqType] = {}
tempDict = {}
aDict = motDict[seqType]
tempMots = filter(lambda x: not len(aDict[x].keys()) ==
len(tempList), aDict.keys())
if tempMots:
for i in tempMots:
theseChr = filter(lambda x: x not in
aDict[i].keys(), tempList)
for j in theseChr:
motDict[seqType][i][j] = []
for i in tempList:
tempSegs = []
dummy = [tempSegs.extend(aDict[y][i]) for y in
aDict.keys()]
tempDict[i] = arrangeSegs(tempSegs)
motDict[seqType]['any'] = tempDict
motifStr = ''
for i in aDict.keys():
motifStr += '\t' + i
lenDict[seqType][i] = {}
lenDict[seqType][i]['tot'] = 0
for j in aDict[i].keys():
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tempSum = sum([x[1] for x in aDict[i][j]])
lenDict[seqType][i][j] = tempSum
lenDict[seqType][i]['tot'] += tempSum
strDict[seqType] = motifStr
tempList.append('tot')
tempStr = ''
if aMot:
if '(' in aMot:
tempStr = aMot[(aMot.index('(') +
1):aMot.index(')')]
else:
tempStr = aMot[0:aMot.index(' ')]
for seqType in motDict.keys():
fOut = open('motifBaseInfo.'+seqType+tempStr+'.txt',
'w')
fOut.write(strDict[seqType] + '\n')
for j in tempList:
fOut.write(j)
tempDict = lenDict[seqType]
for i in tempDict.keys():
thisStr = str(tempDict[i][j]) if j in
tempDict[i].keys() else '0'
fOut.write('\t' + thisStr)
fOut.write('\n')
fOut.close()
return lenDict
def mutBaseInfo(prefix='mut', aMot=''):
fiList = os.listdir(prefix + 'Motifs')

###

motList = []
posDict = {}
for aFile in fiList:
thisPos = aFile.strip('.txt')
posDict[thisPos] = []
fOpen = open(prefix + 'Motifs/' + aFile)
header = fOpen.readline()
for line in fOpen:
lineList = line.split('\t')
motType = lineList[3]
motNom = lineList[4].strip().split(';')

###
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if aMot and motType==aMot:
for aNom in motNom:
if aNom not in motList:
motList.append(aNom)
if aNom not in posDict[thisPos]:
posDict[thisPos].append(aNom)
elif not aMot:
if motType not in motList:
motList.append(motType)
if motType not in posDict[thisPos]:
posDict[thisPos].append(motType)
tempStr = ''
if aMot:
if '(' in aMot:
tempStr = aMot[(aMot.index('(') +
1):aMot.index(')')]
else:
tempStr = aMot[0:aMot.index(' ')]
fOut = open('posMotTable.' + prefix + tempStr + '.txt',
'w')
for i in motList:
fOut.write('\t' + i)
for i in posDict.keys():
fOut.write('\n' + i)
for j in motList:
fOut.write('\t' + ('1' if (j in posDict[i]) else
'0'))
def getBaseCounts():
fRand = open('adjRandomPosListAll.txt')
fOut = open('gctable.txt', 'w')
posList = os.listdir('regrna_results')
fOut.write('Sequence Hash\tSequence Type')
randList = []
header = fRand.readline()
for line in fRand:
lineList = line.split('\t')
randList.append(lineList[0].strip() + '.' +
lineList[1].strip() + '.' + lineList[2].strip())
baseList = ['a', 'c', 't', 'g']
diBaseList = []
dummy = map(lambda x: diBaseList.extend(x), map(lambda y:
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[y + z for z in baseList], baseList))
for i in baseList + diBaseList:
fOut.write('\t' + i.upper() + ' Count')
for i in posList:
aPos = i.strip('.txt')
thisPos = getPos(aPos)
thisChr = thisPos[0]
thisStart = thisPos[1]
thisLen = thisPos[2]
baseCounts = {}
thisSeq = genomelib.get_sequence(thisChr,
int(thisStart), int(thisLen))
lowerSeq = thisSeq.lower()
for k in baseList:
baseCounts[k] = len(filter(lambda x: x==k,
lowerSeq))
for k in diBaseList:
baseCounts[k] = 0
for j in range(len(lowerSeq)-1):
if 'n' not in lowerSeq[j:j+2]:
baseCounts[lowerSeq[j:j+2]] += 1
fOut.write('\n' + aPos + '\t' + ('random' if aPos in
randList else 'variant'))
for k in baseList + diBaseList:
fOut.write('\t' + str(baseCounts[k]))
fOut.close()
def cleanFiles():
fOpen = open('regionsCovered.txt')
header = fOpen.readline()
fileList = []
for line in fOpen:
lineList = line.split('\t')
fileList.append(lineList[0].strip() + '.' +
lineList[1].strip() + '.' + lineList[2].strip() +
'.txt')
fOpen.close()
regrnaList = os.listdir('regrna_results')
counter = 0
for i in regrnaList:
if i not in fileList:
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os.remove('regrna_results/' + i)
counter += 1
print(str(counter) + " files removed.")
def removeEmpty():
fiList = os.listdir('regrna_results')
for i in fiList:
fOpen = open('regrna_results/' + i)
header = fOpen.readline()
tempList = []
for line in fOpen:
tempList.append(line.strip())
if not tempList:
shutil.move('regrna_results/' + i, 'emptyseqs')
def caseMotifs(numType='raw'):
fMuts = open('posMotTable.mut.txt')
header = fMuts.readline()
headerList = header.strip().split('\t')
caseN = 28
caseDict = {}
for i in range(1, caseN+1):
tempNom = 'case' + str(i)
caseDict[tempNom] = {}
caseDict[tempNom]['muts'] = []
for i in headerList:
caseDict[tempNom][i] = 0
caseDict[tempNom]['none'] = 0
caseDict[tempNom]['tot'] = 0
caseDict[tempNom]['totMuts'] = 0
fOpen = open(os.path.expanduser('~/data/' + tempNom +
'/processed/info/' + tempNom +
'.regMuts.filtered.txt'))
for line in fOpen:
lineList = [x.strip() for x in line.split('\t')]
tempHash = lineList[2] + lineList[5] + lineList[6]
+ lineList[3]
if tempHash not in caseDict[tempNom]['muts']:
caseDict[tempNom]['muts'].append(tempHash)
fOpen.close()
for line in fMuts:
lineList = [x.strip() for x in line.split('\t')]
thisHash = lineList[0]
caseList = filter(lambda x: thisHash in
caseDict[x]['muts'],
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caseDict.keys())
for j in caseList:
caseDict[j]['totMuts'] += 1
if all([x=='0' for x in lineList[1:]]):
for j in caseList:
caseDict[j]['none'] += 1
else:
for i in range(1, len(lineList)):
aFlag = False
if int(lineList[i]):
for j in caseList:
caseDict[j][headerList[i-1]] += 1
if not aFlag:
aFlag = True
caseDict[j]['tot'] += 1
fMuts.close()
fOut = open('caseMotInfo.txt', 'w')
fOut.write(header.strip())
fOut.write('\tnone\tTotal Mutations\n')
for i in range(1, caseN+1):
tempNom = 'case' + str(i)
fOut.write(tempNom)
for j in headerList:
if numType == 'raw':
fOut.write('\t' + str(caseDict[tempNom][j]))
else:
fOut.write('\t' +
str(float(caseDict[tempNom][j])/
caseDict[tempNom]['tot']))
fOut.write('\t' + str(caseDict[tempNom]['none']) + '\t'
+ str(caseDict[tempNom]['totMuts']))
fOut.write('\n')
fOut.close()
def seqByType():
fVars = open('poslist2.txt')
fFake = open('fakePosList.reg.buffer.txt')
fFake2 = open('fakeMutList4.txt')
fFake3 = open('fakeMutList.fakeonly.reg.txt')
listDict = {'vars':[], 'fake':[], 'fake2':[], 'fake3':[]}
for line in fVars:
listDict['vars'].append(line.strip())
fVars.close()
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for line in fFake:
listDict['fake'].append(line.strip())
fFake.close()
for line in fFake2:
listDict['fake2'].append(line.strip())
fFake2.close()
for line in fFake3:
listDict['fake3'].append(line.strip())
fFake3.close()
seqCount = {'vars':{'count':0, 'list':[]},
'fake':{'count':0, 'list':[]},
'fake2':{'count':0, 'list':[]},
'fake3':{'count':0, 'list':[]}}
for i in listDict.keys():
for j in listDict[i]:
if checkIfCovered(j):
tempCov = getCover(j)
if checkIfFileExists(tempCov) and tempCov not
in seqCount[i]['list']:
seqCount[i]['count'] += 1
seqCount[i]['list'].append(tempCov)
for i in seqCount.keys():
print i, seqCount[i]['count']
def getAllChrMotifs():
global gloMotDict
allChr = os.listdir('motifInfo')
for i in allChr:
gloMotDict[i.strip('.tx').strip('chr')] =
procChrMotifs(i)
gloChrDict = readRegions()
gloMotDict = {}
1.7 hgTables_slim.py
import sys, os, re
import random
from genomicode import genomelib
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from run_regrna import getPos
def slimFiles():
fOpen = open('hgTables.txt')
geneDict = {}
header = fOpen.readline()
for line in fOpen:
if line.strip():
lineList = line.split('\t')
thisGene = lineList[12]
if thisGene not in geneDict:
geneDict[thisGene] = {'start':
int(lineList[4]), 'end':int(lineList[5]),
'chr':lineList[2]}
else:
geneDict[thisGene]['start'] =
min(geneDict[thisGene]['start'],
int(lineList[4]))
geneDict[thisGene]['end'] =
max(geneDict[thisGene]['end'],
int(lineList[5]))
fOpen.close()
fOut = open('hgTables.slim.txt', 'w')
fOut.write('Gene\tChromosome\tStart\tEnd')
for i in geneDict.keys():
fOut.write('\n' + i + '\t' + geneDict[i]['chr'] +
'\t' + str(geneDict[i]['start']) + '\t' +
str(geneDict[i]['end']))
fOut.close()
def orgSegs():
fOpen = open('hgTables.slim.txt')
chrDict = {}
header = fOpen.readline()
for line in fOpen:
lineList = line.split('\t')
thisChr = lineList[1]
if thisChr not in chrDict:
chrDict[thisChr] = []
posStart = int(lineList[2])-25000
if posStart < 0:
posStart = 0
posEnd = int(lineList[3])+25000
chrDict[thisChr].append((posStart, posEnd))
fOpen.close()
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chrList = ['chr' + str(x) for x in range(1, 23)]
chrList.append('chrX')
chrList = filter(lambda x: x in chrDict.keys(), chrList)
sortChrDict = {}
for i in chrList:
posList = chrDict[i]
posList.sort(key=lambda x: x[0])
tempList = []
tempTup = (0,0)
for j in posList:
if (j[0] <= tempTup[1] and j[0] >= tempTup[0]) or
(j[1] <= tempTup[1] and j[1] >= tempTup[0]):
tempTup = (min(tempTup[0], j[0]),
max(tempTup[1], j[1]))
else:
if not tempTup==(0,0):
tempList.append(tempTup)
tempTup=j
if not tempList and not tempTup==(0,0):
tempList.append(tempTup)
sortChrDict[i] = tempList
return sortChrDict
def pickRan(aNum=1000):
chrDict = orgSegs()
lenDict = {}
proDict = {}
for i in chrDict.keys():
lenDict[i] = [x[1]-x[0]+1 for x in chrDict[i]]
tempList = [float(x)/sum(lenDict[i]) for x in
lenDict[i]]
proDict[i] = [sum(tempList[0:x]) for x in range(1,
len(tempList)+1)]
randChr = [random.choice(chrDict.keys()) for x in
range(aNum)]
posList = []
while len(posList) < aNum:
i = randChr[len(posList)]
thisList = proDict[i]
ranNum = random.random()
temp = filter(lambda x: x >= ranNum, thisList)
thisRange = chrDict[i][0]
thisPos = random.randint(thisRange[0], thisRange[1])
tempHash = i.strip('chr') + 'NN' + str(thisPos)
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if tempHash not in posList and thisPos > 200 and not
genomelib.get_sequence(i.strip('chr'), thisPos,
1).lower()=='n':
posList.append(tempHash)
fOut = open('fakePosList4.txt', 'w')
for i in posList:
fOut.write(i + '\n')
def getExons():
fOpen = open('hgTables.txt')
header = fOpen.readline()
chrDict = {}
for line in fOpen:
if line:
lineList = line.split('\t')
thisChr = lineList[2].strip('chr')
if thisChr not in chrDict:
chrDict[thisChr] = []
exStarts = lineList[9].strip(',').split(',')
exEnds = lineList[10].strip(',').split(',')
for i in range(len(exStarts)):
chrDict[thisChr].append((int(exStarts[i]),
int(exEnds[i])))
fOpen.close()
return chrDict
def cleanExon():
chrDict = getExons()
fOpen = open('fakePosList4.txt')
posList = []
for line in fOpen:
posList.append(line)
fOpen.close()
fOut = open('fakePosList4.reg.txt', 'w')
for i in posList:
thisPos = getPos(i)
thisChr = thisPos[0]
thisBase = int(thisPos[1])
if thisChr in chrDict:
theseEx = chrDict[thisChr]
if not any([x[0] <= thisBase and thisBase<=x[1] for
x in theseEx]):
fOut.write(i)
fOut.close()
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1.8 regression2.R
setwd("H:/Documents/Actual documents")
library(gplots)
library(survival)
caseInfo <- read.table('caseMotInfo.txt', quote='', header=T,
sep='\t')
caseInfo.order <- caseInfo[order(caseInfo[,1]),]
####
keggInfo <- read.table('allPathsScores.dled.txt', quote='',
header=T, sep='\t')
keggInfo.order <- keggInfo[order(keggInfo[,1]),]
keggCoding <- read.table('allPaths_codMuts.txt', quote='',
header=T, sep='\t')
keggCoding.order <- keggCoding[order(keggCoding[,1]),]
###
pathList = colnames(keggInfo)[-1:-2]
outList = list()
for(aPath in pathList){
caseInfo.temp <- cbind(caseInfo.order,
keggCoding[,aPath])
colnames(caseInfo.temp) <- c(colnames(caseInfo.order),
'Coding.Muts')
linMat <-cbind(keggInfo[,aPath],
sweep(caseInfo.temp[,c(2:20,22)],1,(caseInfo.temp$Total.M
utations+caseInfo.temp$Coding.Muts),'/'))
colnames(linMat) <- c('Score', 'ncRNA', 'longStems',
'funcRNA', 'miRNA', 'Transcript', 'RIT', 'PAS', 'ISE',
'ORF', 'ESE', 'ERPIN', 'ESS', 'UTR', 'ARE', 'Splicing',
'RBS', 'ISS', 'C2U', 'none', 'Coding')
rownames(linMat) <- caseInfo.temp[,1]
tempList = list()
kccModel <- lm(Score ~
0+ncRNA+longStems+funcRNA+miRNA+Transcript+RIT+PAS+ISE+
ORF+ESE+ERPIN+ESS+UTR+ARE+Splicing+RBS+ISS+C2U,
data=linMat)
kccModel.code <- lm(Score ~ 0+Coding, data=linMat)
kccModel.all <- lm(Score ~
0+ncRNA+longStems+funcRNA+miRNA+Transcript+RIT+PAS+ISE+
ORF+ESE+ERPIN+ESS+UTR+ARE+Splicing+RBS+ISS+C2U+Coding,
data=linMat)
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kccModel.sig <- lm(Score ~
0+ncRNA+Splicing+longStems+ORF+RIT+miRNA+funcRNA+
Transcript+ESE+ESS+ISE+Coding, data=linMat)
tempList[['NC']] <- summary(kccModel)
tempList[['Code']] <- summary(kccModel.code)
tempList[['All']] <- summary(kccModel.all)
tempList[['Sig']] <- summary(kccModel.sig)
outList[[aPath]] = tempList
}
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